Baird Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,588
| Closed | -$157K | – | 1934 |
|
|
2021
Q4 | $157K | Buy |
+19,588
| New | +$177K | ﹤0.01% | 1838 |
|
|
2021
Q3 | – | Sell |
-11,527
| Closed | -$114K | – | 1926 |
|
|
2021
Q2 | $114K | Buy |
+11,527
| New | +$122K | ﹤0.01% | 1726 |
|
|
2019
Q4 | – | Sell |
-15,773
| Closed | -$109K | – | 1550 |
|
|
2019
Q3 | $109K | Sell |
15,773
-3,956
| -20% | -$30.3K | ﹤0.01% | 1479 |
|
|
2019
Q2 | $182K | Sell |
19,729
-17,725
| -47% | -$214K | ﹤0.01% | 1474 |
|
|
2019
Q1 | $587K | Sell |
37,454
-13,282
| -26% | -$234K | ﹤0.01% | 982 |
|
|
2018
Q4 | $782K | Sell |
50,736
-1,313
| -3% | -$26.9K | 0.01% | 869 |
|
|
2018
Q3 | $1.12M | Buy |
52,049
+8,248
| +19% | +$191K | 0.01% | 823 |
|
|
2018
Q2 | $1.06M | Buy |
43,801
+7,908
| +22% | +$161K | 0.01% | 817 |
|
|
2018
Q1 | $613K | Buy |
35,893
+9,689
| +37% | +$189K | ﹤0.01% | 957 |
|
|
2017
Q4 | $497K | Sell |
26,204
-113,390
| -81% | -$1.71M | ﹤0.01% | 1011 |
|
|
2017
Q3 | $2.46M | Sell |
139,594
-77,638
| -36% | -$1.75M | 0.02% | 568 |
|
|
2017
Q2 | $7.22M | Sell |
217,232
-25,622
| -11% | -$793K | 0.06% | 326 |
|
|
2017
Q1 | $7.79M | Buy |
242,854
+96,300
| +66% | +$3.29M | 0.06% | 304 |
|
|
2016
Q4 | $5.31M | Buy |
146,554
+28,373
| +24% | +$1.13M | 0.05% | 362 |
|
|
2016
Q3 | $5.44M | Buy |
118,181
+7,823
| +7% | +$408K | 0.05% | 350 |
|
|
2016
Q2 | $5.92M | Buy |
110,358
+34,177
| +45% | +$1.82M | 0.05% | 332 |
|
|
2016
Q1 | $4.08M | Buy |
76,181
+7,710
| +11% | +$452K | 0.04% | 390 |
|
|
2015
Q4 | $4.49M | Buy |
68,471
+3,850
| +6% | +$238K | 0.04% | 366 |
|
|
2015
Q3 | $3.65M | Sell |
64,621
-36,746
| -36% | -$2.38M | 0.04% | 391 |
|
|
2015
Q2 | $5.99M | Buy |
+101,367
| New | +$6.25M | 0.06% | 298 |
|
Other funds holding TEVA
ACM
MMH
MIFH
CI
PF
HIIFS